Ares Commercial Real Estate Insider Shake‑Up: What Professionals Should Know This Week

Modern suburban homes

If your morning coffee pairs well with a dash of market intrigue, today’s spotlight lands squarely on Ares Commercial Real Estate Corporation (NYSE:ACRE). The company’s CEO & Director, Bryan Donohoe, recently sold US$107k worth of shares at an average price of US$4.93—a move that trimmed his personal stake by roughly 13%.

Insider activity doesn’t always spell trouble, but it always sparks questions. And in today’s evolving market landscape, Florida real estate agents, mortgage professionals, and investment‑minded specialists nationwide should keep an eye on moves like these. Understanding market behavior is part of staying competitive—something we take seriously at Cameron Academy as we help professionals stay informed, licensed, and ahead of industry shifts.

A Bigger Pattern? Understanding ACRE Insider Behavior

This isn’t Donohoe’s first sale of the year. Earlier, he sold approximately US$133k worth of shares at US$5.68 per share—meaning his earlier sale happened at a stronger price point. While insider selling is common, repeated sales without any insider buying can raise eyebrows among seasoned investors.

According to the data, insiders at Ares Commercial Real Estate made no purchases in the past 12 months. That doesn’t automatically signal danger, but it does create a tone of caution from within the leadership ranks.

See the Full Insider Activity Chart

Want to explore every insider transaction from the past year? View the interactive chart here and dig into dates, prices, and individual trades.

How Much Skin Do Insiders Have in the Game?

Insider ownership sits at about 1.6%—worth roughly US$4.6 million. While not insignificant, it isn’t especially high either. Lower insider ownership often correlates with lower long-term alignment, though it doesn’t always indicate poor performance.

As the Simply Wall St analysis suggests, many companies show stronger internal confidence through larger insider holdings. ACRE’s numbers are conservative but not alarming.

What Should Professionals Take Away?

Insiders sold stock recently, and none showed buying activity. Combined with modest insider ownership, the indicators suggest a measured caution. Still, insider selling by itself is not a forecast of decline—it’s simply one piece of a much larger market puzzle.

For professionals navigating real estate, finance, and investment spaces, this serves as a reminder of the importance of market literacy. Whether you’re evaluating REITs, shaping a portfolio, or watching economic signals, staying informed is essential. If you’re growing your career or expanding your license portfolio, Cameron Academy provides the educational backbone to help keep you competitive and current.

More From the Source

Explore the full analysis, discover small-cap stocks insiders are buying, or try their free portfolio tools:

Insider‑Bought Small Caps
Try the Free Portfolio Companion
Contact the Editorial Team

And as always: this information isn’t financial advice—but it does help you stay sharp, curious, and one step ahead as you navigate the day’s headlines.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Gene Editing: A Promising Frontier in Biotechnology

Gene editing technology is swiftly emerging as a transformative force in both healthcare and agriculture, particularly through tools like CRISPR-Cas9, which offer precise methods to modify genes and promise to revolutionize treatment for genetic disorders, cancer, and infectious diseases.

Empowering the Gig Economy: AXA’s Tailored Protection

Angela Wong, Chief Marketing and Customer Officer at AXA Hong Kong & Macau, underscores the critical need for comprehensive insurance solutions for gig workers.

By |November 24, 2024|Categories: Article, Business, Insurance|Tags: , |0 Comments

Ethical Deployment of AI in Healthcare: AMA’s Guiding Strategies

The AMA highlights that AI's integration must be guided by the fundamental principles of medical ethics: patient autonomy, beneficence, nonmaleficence, and justice.

By |November 24, 2024|Categories: Article, Healthcare, Technology Ethics|Tags: , |0 Comments

AI’s Role in Revolutionizing Medical Education

AI, which simulates human intelligence, is reshaping various sectors, particularly healthcare. The ability to perform complex tasks, such as diagnostics and personalized healthcare, is no longer confined to human capabilities alone.

By |November 23, 2024|Categories: Article, Education, Technology|Tags: , |0 Comments

AI Chatbots in Chronic Disease Diagnosis

A recent study published in Nature on July 25, 2024, unveils a cutting-edge chatbot named Chat Ella, designed to assist in the diagnosis of chronic diseases.

Revolutionizing Genetic Research with CRISPR-Cas Technology

CRISPR-Cas technology is not just a tool but a gateway to understanding the genetic influences on diseases.